Effects of long-term treatment with corticosteroids in COPD

Chest

Volumn 109, Issue 5, 1996, Pages 1156-1162

  Renkema, Tineke E J ^a   Schouten, Jan P ^a   Koëter, Gerard H ^a   Postma, Dirkje S ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

budesonide; chronic obstructive pulmonary disease; corticosteroids; exacerbations; FEV1; prednisolone; symptoms

Indexed keywords

BUDESONIDE; CORTICOSTEROID; HYDROCORTISONE; PLACEBO; PREDNISOLONE;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; FORCED EXPIRATORY VOLUME; HUMAN; HYDROCORTISONE BLOOD LEVEL; INHALATIONAL DRUG ADMINISTRATION; LONG TERM CARE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOMATOLOGY;

EID: 0029866161     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.109.5.1156     Document Type: Article

References (32)

1. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma. Am Rev Respir Dis 1993; 148:S1-26
2. Postma DS, Renkema TEJ, Koeter GH. Effects of corticosteroids in 'chronic bronchitis' and 'chronic obstructive airway disease.' Agents Actions 1990; 30(suppl):41-57
3. Callahan CM, Dittus RS, Katz BP. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease: a meta-analysis. Ann Intern Med 1991; 114:216-23
4. Wedzicha JA. Inhaled corticosteroids in COPD: awaiting controlled trials [editorial]. Thorax 1993; 48:305-07
5. Postma DS, Steenhuis EJ, van der Weele LTh, et al. Severe chronic airflow obstruction: can corticosteroids slow down progression? Eur J Respir Dis 1985; 67:56-64
6. Postma DS, Peters I, Steenhuis EJ, et al. Moderately severe chronic airflow obstruction: can corticosteroids slow down progression? Eur Respir J 1988; 1:22-6
7. Kerstjens HAM, Brand PLP, Hughes MD, et al. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 1992; 327:1413-19
8. Dompeling E, van Sehayck CP, Molema J, et al. Inhaled beclomethasone improves the course of asthma and COPD. Eur Respir J 1992; 5:945-52
9. Carnilli AE, Burrows B, Knudson R, et al. Longitudinal changes in forced expiratory volume in one second in adults: effects of smoking and smoking cessation. Am Rev Respir Dis 1987; 135:794-99
10. Nocturnal Oxygen Therapy Trial Group. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Ann Intern Med 1980; 93:391-98
11. Medical Research Council Working Party. Long term domiciliary oxygen therapy in chronic hypoxemic cor pulmonale complicating chronic bronchitis and emphysema. Lancet 1981; 1:681-86
12. Cotes JE. Lung function: assessment and application in medicine. 4th ed. Oxford: Blackwell Scientific Productions, 1979; 114, 118
13. Quanjer PhH, ed. Standardized lung function testing. Eur Respir J 1993; 6(suppl 16):1-100
14. de Vries K, Goei JT, Booy-Noord H, et al. Changes during 24 hours in the lung function and histamine hyperreactivity of the bronchial tree in asthmatic and bronchitic patients. Int Arch Allergy 1962; 20:93-101
15. Ferron GA, Kerrebijn KF, Weber J. Properties of aerosols produced with nebulizers commonly used in medicine. Am Rev Respir Dis 1976; 114:899-908
16. + V2.0 base manual. Chicago: SPSS Inc. 1988
17. Colton T. Statistics in medicine. 1st ed. Boston: Little Brown, 1974
18. Fletcher C, Pero R, Tiuker C, et al. The natural history of chronic bronchitis and emphysema. Oxford: Oxford University Press, 1976
19. Kauffman F, Drouet D, Lellouch J, et al. Twelve years spirometric changes among Paris area workers. Int J Epidemiol 1979; 8:201-12
20. Weir DC, Gove RI, Robertson AS, et al. Corticosteroid trials in nonasthmatic chronic airflow obstruction: a comparison of oral prednisolone and inhaled beclomethasone dipropionate. Thorax 1990; 45:112-17
21. Mendella LA, Manfreda J, Warren CPW, et al. Steroid response in stable chronic obstructive pulmonary disease. Ann Intern Med 1982; 96:17-21
22. Petty TL, Brink GA, Miller MW, et al. Objective functional improvement in chronic airway obstruction. Chest 1970; 57:216-23
23. 1 during long term inhaled corticosteroid treatment. Eur Respir J 1993; 6:868-76
24. Harding SM, Freedman S. A comparison of oral and inhaled steroids in patients with chronic airways obstruction: features determining response. Thorax 1978; .33:214-18
25. Shim C, Stover DE, Williams MH Jr. Response to corticosteroids in chronic bronchitis. J Allergy Clin Immunol 1978; 62:363-67
26. Sahn SA. Corticosteroids in chronic bronchitis and pulmonary emphysema. Chest 1978; 73:389-96
27. Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients. N Engl J Med 1969: 280;397-404
28. Postma DS, Burema J, Gimeno F, et al. Prognosis in severe chronic obstructive pulmonary disease. Am Rev Respir Dis 1979; 119:357-67
29. Anthonisen NR, Wright EC, Hodgkin JE, et al. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133:14-20
30. Traver GA, Cline MG, Burrows B. Predictors of mortality in chronic obstructive pulmonary disease: a 15-year follow-up study. Am Rev Respir Dis 1979; 119:895-902
31. Barter LE, Campbell AH. Relationship of constitutional factors and smoking to decrease in 1-second forced expiratory volume. Am Rev Respir Dis 1976; 113:305-14
32. Kanner RE, Renzetti AD, Klauber MR, et al. Variables associated with changes in spirometry in patients with obstructive lung disease. Am J Med 1979; 67:44-50